1ND5
Crystal Structures of Human Prostatic Acid Phosphatase in Complex with a Phosphate Ion and alpha-Benzylaminobenzylphosphonic Acid Update the Mechanistic Picture and Offer New Insights into Inhibitor Design
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU RU200 |
Temperature [K] | 298 |
Detector technology | IMAGE PLATE |
Collection date | 1997-12-01 |
Detector | RIGAKU RAXIS IV |
Wavelength(s) | 1.5418 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 120.100, 204.860, 71.220 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 50.000 * - 2.900 |
R-factor | 0.2051 |
Rwork | 0.205 |
R-free | 0.27800 * |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | 2hpa |
RMSD bond length | 0.007 * |
RMSD bond angle | 1.300 * |
Data reduction software | HKL-2000 |
Data scaling software | SCALEPACK |
Phasing software | CNS |
Refinement software | CNS |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 3.000 |
High resolution limit [Å] | 2.900 * | 2.890 |
Rmerge | 0.063 | |
Number of reflections | 33191 | |
Completeness [%] | 82.2 | 63.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | unknown * | 10 | 298 | PEG, KCL, Glycine, pH 10.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K |
Crystallization Reagents in Literatures
ID | crystal ID | solution | reagent name | concentration (unit) | details |
1 | 1 | 1 | protein | 7-10 (mg/ml) | |
2 | 1 | 1 | PEG1500 | 30 (%) | |
3 | 1 | 1 | PEG1000 | 7 (%) | |
4 | 1 | 1 | PEG400 | 6 (%) | |
5 | 1 | 1 | 100 (mM) | ||
6 | 1 | 1 | glycine | 100 (mM) | pH10.0 |